Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Imetelstat (GRN163L, NSC# 754228) in Children With Relapsed or Refractory Solid Tumors

NCT02011126 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT02011126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02011126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Imetelstat (GRN163L, NSC# 754228) in Children With Relapsed or Refractory Solid Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Withdrawn
Start date
June 30, 2014
Completion date
Not reported
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatoblastoma, previously treated childhood rhabdomyosarcoma, recurrent childhood liver cancer, recurrent childhood rhabdomyosarcoma, recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor, recurrent neuroblastoma, recurrent osteosarcoma, rhabdomyosarcoma